GlaxoSmithKline Pakistan Limited’s close period- financial results for the half-year ended June 30, 2011
Karachi: Please be informed that today the Company has made Announcement of Closed Period from August 16, 2011 to August 23, 2011 (both days inclusive) having regard to the Meeting of the Board of Directors to be held on August 23, 2011, for consideration of the Financial Results of the Company for the half-year ended June 30, 2011.
Accordingly, the employees of the Company including its Directors and Executives have been communicated the Closed Period, as required. Copy of the communication is enclosed.
In compliance with the Code of Corporate Governance as incorporated in the Listing Regulations of the Karachi and Lahore Stock Exchanges, the under mentioned period has been determined as a Closed Period in connection with the Meeting of the Board of Directors of the Company to be held on August 23, 2011 for consideration of Financial Accounts for the second quarter 2011.
Therefore, no Director or Executive shall directly or indirectly, deal in the shares of GlaxoSmithKline Pakistan Limited in any manner during the following Closed Period:
Closed Period: August 16, 2011 up to August 23, 2011
All trades in the shares, of GlaxoSmithKline Pakistan Limited carried out by Directors and Executives, their spouses and minor shall be disclosed Company Secretary effecting the transaction.
The above instruction must be fallowed in compliance with statutory requirement.
For more information, contact:
GlaxoSmithKline Pakistan Limited
35 Dockyard Road,
Tel: 92-21 32315478-82
Fax: 92-21 32314898